Regulation of Baicalin on Growth of Extranodal NK/T Cell Lymphoma Cells through FOXO3/CCL22 Signaling Pathway.
10.19746/j.cnki.issn.1009-2137.2023.03.017
- Author:
Xiao-Hui DUAN
1
;
Hong LI
2
;
Yao LYU
3
;
Jing LIU
3
;
Shi-Xiong WANG
3
;
Zhen-Tian WU
3
;
Bing-Xuan WANG
3
;
Ming LU
3
;
Jian-Hong WANG
4
;
Rong LIANG
5
Author Information
1. The Second Clinical Medical College of Shaanxi University of Chinese Medicine, Xi'an 712046, Shaanxi Province, China,Department of Hematology, The First Affiliated Hospital of Air Force Military Medical University, Xi'an 710032, Shaanxi Province, China.
2. The Second Clinical Medical College of Shaanxi University of Chinese Medicine, Xi'an 712046, Shaanxi Province, China.
3. Department of Hematology, The First Affiliated Hospital of Air Force Military Medical University, Xi'an 710032, Shaanxi Province, China.
4. Department of Hematology, The First Affiliated Hospital of Air Force Military Medical University, Xi'an 710032, Shaanxi Province, China,119248054@qq.com.
5. Department of Hematology, The First Affiliated Hospital of Air Force Military Medical University, Xi'an 710032, Shaanxi Province, China, rongliang1017@gmail.com.
- Publication Type:Journal Article
- Keywords:
CCL22;
FOXO3;
baicalin;
extranodal NK/T cell lymphoma
- MeSH:
Animals;
Mice;
Humans;
Lymphoma, Extranodal NK-T-Cell/pathology*;
Forkhead Box Protein O3/metabolism*;
bcl-2-Associated X Protein/pharmacology*;
Mice, Nude;
Signal Transduction;
Apoptosis;
Proto-Oncogene Proteins c-bcl-2/metabolism*;
Chemokine CCL22/pharmacology*
- From:
Journal of Experimental Hematology
2023;31(3):730-738
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect of baicalin on the growth of extranodal NK/T cell lymphoma (ENKTCL) cells and its related mechanism.
METHODS:Normal NK cells and human ENKTCL cells lines SNK-6 and YTS were cultured, then SNK-6 and YTS cells were treated with 5, 10, 20 μmol/L baicalin and set control. Cell proliferation and apoptosis was detected by Edu method and FCM method, respectively, and expressions of BCL-2, Bax, FOXO3 and CCL22 proteins were detected by Western blot. Interference plasmids were designed and synthesized. FOXO3 siRNA interference plasmids and CCL22 pcDNA overexpression plasmids were transfected with PEI transfection reagent. Furthermore, animal models were established for validation.
RESULTS:In control group and 5, 10, 20 μmol/L baicalin group, the proliferation rate of SNK-6 cells was (56.17±2.96)%, (51.92±4.63)%, (36.42±1.58)%, and (14.60±2.81)%, respectively, while that of YTS cells was (58.85±2.98)%, (51.38±1.32)%, (34.75±1.09)%, and (15.45±1.10)%, respectively. In control group and 5, 10, 20 μmol/L baicalin group, the apoptosis rate of SNK-6 cells was (5.93±0.74)%, (11.78±0.34)%, (28.46±0.44)%, and (32.40±0.37)%, respectively, while that of YTS cells was (7.93±0.69)%, (16.29±1.35)%, (33.91±1.56)%, and (36.27±1.06)%, respectively. Compared with control group, the expression of BCL-2 protein both in SNK-6 and YTS cells decreased significantly (P<0.001), and the expression of Bax protein increased in SNK-6 cells only when the concentration of baicalin was 20 μmol/L (P<0.001), while that in YTS cells increased in all three concentrations(5, 10, 20 μmol/L) of baicalin (P<0.001). The expression of FOXO3 protein decreased while CCL22 protein increased in ENKTCL cell lines compared with human NK cells (P<0.001), but the expression of FOXO3 protein increased (P<0.01) and CCL22 protein decreased after baicalin treatment (P<0.001). Animal experiments showed that baicalin treatment could inhibit tumor growth. The expression of CCL22 protein in ENKTCL tissue of nude mice treated with baicalin decreased compared with control group (P<0.01), while the FOXO3 protein increased (P<0.05). In addition, FOXO3 silencing resulted in the decrease of FOXO3 protein expression and increase of CCL22 protein expression (P<0.01, P<0.001).
CONCLUSION:Baicalin can inhibit proliferation and promote apoptosis of ENKTCL cell lines SNK-6 and YTS, up-regulate the expression of Bax protein, down-regulate the expression of BCL-2 protein, and down-regulate the expression of CCL22 protein mediated by FOXO3. Animal experiment shown that the baicalin can inhibit tumor growth. Baicalin can inhibit the growth and induce apoptosis of ENKTCL cells through FOXO3/CCL22 signaling pathway.
